Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8405066rdf:typepubmed:Citationlld:pubmed
pubmed-article:8405066lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:8405066lifeskim:mentionsumls-concept:C0038164lld:lifeskim
pubmed-article:8405066lifeskim:mentionsumls-concept:C0021024lld:lifeskim
pubmed-article:8405066lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:8405066lifeskim:mentionsumls-concept:C0439828lld:lifeskim
pubmed-article:8405066lifeskim:mentionsumls-concept:C0358321lld:lifeskim
pubmed-article:8405066pubmed:issue10lld:pubmed
pubmed-article:8405066pubmed:dateCreated1993-11-12lld:pubmed
pubmed-article:8405066pubmed:abstractTextStaphylococcal protein A (SPA) has two distinct binding sites on human immunoglobulins. In addition to binding to the Fc region of most IgG molecules, an "alternative" binding site has been localized to the Fab region of human immunoglobulins encoded by heavy chain variable gene segments belonging to the VHIII family. Comparison of amino acid sequences of closely related SPA-binding and -non-binding proteins suggested that VHIII-specific residues in the second complementarity-determining region (CDR2) were likely responsible for SPA binding activity. Site-directed mutagenesis of a single amino acid residue in CDR2 converted an IgM rheumatoid factor which did not bind SPA to an SPA binder. These findings, therefore, locate a critical site involved in SPA binding to the CDR2 of human immunoglobulins encoded by VHIII family gene segments.lld:pubmed
pubmed-article:8405066pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8405066pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8405066pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8405066pubmed:languageenglld:pubmed
pubmed-article:8405066pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8405066pubmed:citationSubsetIMlld:pubmed
pubmed-article:8405066pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8405066pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8405066pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8405066pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8405066pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8405066pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8405066pubmed:statusMEDLINElld:pubmed
pubmed-article:8405066pubmed:monthOctlld:pubmed
pubmed-article:8405066pubmed:issn0014-2980lld:pubmed
pubmed-article:8405066pubmed:authorpubmed-author:LUMMlld:pubmed
pubmed-article:8405066pubmed:authorpubmed-author:CapraJ DJDlld:pubmed
pubmed-article:8405066pubmed:authorpubmed-author:NatvigJ BJBlld:pubmed
pubmed-article:8405066pubmed:authorpubmed-author:FørreOOlld:pubmed
pubmed-article:8405066pubmed:authorpubmed-author:PotterK NKNlld:pubmed
pubmed-article:8405066pubmed:authorpubmed-author:PascualVVlld:pubmed
pubmed-article:8405066pubmed:authorpubmed-author:ThompsonK MKMlld:pubmed
pubmed-article:8405066pubmed:authorpubmed-author:RandenIIlld:pubmed
pubmed-article:8405066pubmed:issnTypePrintlld:pubmed
pubmed-article:8405066pubmed:volume23lld:pubmed
pubmed-article:8405066pubmed:ownerNLMlld:pubmed
pubmed-article:8405066pubmed:authorsCompleteYlld:pubmed
pubmed-article:8405066pubmed:pagination2682-6lld:pubmed
pubmed-article:8405066pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:meshHeadingpubmed-meshheading:8405066-...lld:pubmed
pubmed-article:8405066pubmed:year1993lld:pubmed
pubmed-article:8405066pubmed:articleTitleComplementarity-determining region 2 is implicated in the binding of staphylococcal protein A to human immunoglobulin VHIII variable regions.lld:pubmed
pubmed-article:8405066pubmed:affiliationInstitute of Immunology and Rheumatology, Oslo, Norway.lld:pubmed
pubmed-article:8405066pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8405066pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8405066pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8405066lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8405066lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8405066lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8405066lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8405066lld:pubmed